Loading
Latest filing published 22 Mar 2016 for Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.), €68k.
No signal scores available.
One trade, one date: on 22 March 2016, Calvin R. Stiller disclosed an open-market purchase of €68k in Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.). No broader history exists yet. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration